Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.
No one likes surprises when it comes to earnings, and PDD Holdings (NasdaqGS:PDD) just delivered a mixed set of results that is sure to get investors talking. The company’s second quarter report showed sales ticking higher compared to last year, but net income drifted lower over both the quarter and the half-year. That kind of split performance creates plenty of debate for anyone deciding what to do next, especially when the share price has been anything but quiet.
Since the start of the...
KBR (KBR) has landed in the spotlight after the U.S. Transportation Command terminated the company’s role in the Global Household Goods Contract, a move that sent its shares sliding and triggered a class action investigation. Legal proceedings are now underway, with prominent firms examining whether shareholders were misled about the business impact. The contract’s abrupt loss and the resulting scrutiny are front and center for anyone weighing what comes next for KBR and its stock.
This...
If you’re following Crocs (CROX), there’s been quite a bit of leadership news to consider. The company just named Patraic Reagan as its new Chief Financial Officer, stepping in for Susan Healy, who resigned abruptly. Crocs also reaffirmed its financial outlook for the third quarter, signaling a vote of confidence from management as it navigates this executive shakeup. With Reagan’s background at well-known consumer brands like SharkNinja and Nike, investors are likely wondering what his...
Southern (SO) just made a splash with two big announcements that have investors sitting up and taking notice. The company got the green light for five new utility-scale solar projects in Georgia while also raising its five-year base capital plan from $63 billion to $76 billion. Both moves reinforce Southern’s commitment to growing its renewable energy footprint and addressing the Southeast’s soaring electricity demand, especially from data centers and advanced manufacturing. It is a double...
Zillow Group (ZG) has just grabbed attention with a new partnership, this time teaming up with Berkshire Hathaway HomeServices to bring Zillow Showcase, its AI-driven premium listing tool, to a wider network of U.S. agents. The move isn’t just about signing a fresh agreement; it’s about leveraging digital marketing to help listings stand out, sell faster, and fetch higher prices. The latest rollout builds on an earlier collaboration with HomeServices of America, pointing to growing trust in...
If you’ve been watching Agilent Technologies (A) lately, the most recent quarter probably grabbed your attention. The company just posted earnings that came in ahead of forecasts, with both revenue and net income up compared to last year’s third quarter. In addition, Agilent raised its guidance for the rest of fiscal 2025, highlighting stronger than expected business trends and a more confident growth outlook. Investors are now left wondering if this is a signal to reconsider where the...
Amgen (AMGN) just received expanded FDA approval for its cholesterol-lowering drug, Repatha, allowing doctors to prescribe it to an even broader pool of adults at risk for heart disease. Unlike the prior label, which was restricted to people already diagnosed with cardiovascular conditions, the new approval means more patients than ever may now qualify. This is an important shift that could drive commercial uptake in the coming quarters. For investors, this regulatory win is a sizable...
If you're following Zscaler (ZS), the company just reported its annual and fourth-quarter results, serving up a mix of growing revenue and updated guidance for the year ahead. This type of data-rich announcement often puts the spotlight on what investors should do next, especially when it arrives alongside forward-looking expectations. With revenue for the full year rising compared to last year and management offering a fresh look at what they anticipate next, the conversation now shifts from...
For anyone watching Austal (ASX:ASB), the latest earnings announcement is hard to ignore. The company just reported a leap in both sales and net income for the full year, outpacing last year’s numbers by a wide margin. When a company posts this kind of growth after years of steady expansion, it tends to get investors asking whether there’s more upside ahead, or if the news has made the stock a crowded trade.
The market has certainly noticed the news. Austal’s share price has climbed 21% in...
Chemours (NYSE:CC) just made a move that will have shareholders talking at their next check-in. The company’s longtime Chair, Dawn Farrell, has officially stepped down to lead a new Major Projects Office for Canada’s government. In her place, Chemours’ Board tapped independent director Mary Cranston as the new Chair and named Alister Cowan, with a deep financial background, as Lead Independent Director. These appointments are not only about filling seats; they reinforce the Board’s push for...
If you’ve been keeping an eye on lululemon athletica (LULU) lately, you know investors just got a lot to digest. The athletic retailer’s recent earnings revealed that its core U.S. business is under pressure, with sales dipping especially in popular lounge and social product categories. Meanwhile, management pointed to higher tariffs and the removal of the de minimis exemption as key headwinds likely to impact profits in the near term, signaling to the market that cost pressures are climbing...
Innodata (INOD) has just raised eyebrows by lifting its 2025 organic revenue growth forecast to about 45% year over year, up from its previous expectation of 40%. The message from management is clear: demand for its generative AI and Agentic AI services is not just strong, it is accelerating. This move comes on the heels of securing substantial new projects with its largest existing customer as well as adding another major tech company to its roster. These are signals that Innodata’s AI...
Lundin Mining (TSX:LUN) just wrapped up a busy quarter, announcing updates on its share capital and confirming the continuation of its share buyback program. The company also reported its second quarter earnings and declared a dividend, all while doubling down on exploration and expansion projects across its operations. With disciplined acquisition plans still in focus, these moves are giving investors fresh insight into Lundin’s evolving strategy and long-term goals.
This string of...
Flex LNG (NYSE:FLNG) has just reached an important milestone for investors, with its shares now trading ex-dividend after the company declared a USD 0.75 per share payout. This event, while anticipated by those following the company’s dividend schedule, often triggers reactions among traders looking to capture or reposition around dividend payments. The move signals Flex LNG’s ongoing commitment to returning capital to its shareholders, and it could reshape short-term sentiment as markets...
Carvana (CVNA) is turning heads once again, as its shares have continued to make waves in the market. For investors wondering what to do next, the past month’s movement might feel like a crossroads. Is the volatility a signal, or just noise in a sector known for its ups and downs? Nothing in particular has triggered the latest round of trading, yet the company’s steady presence near new highs is prompting plenty of conversations among market-watchers.
Momentum has been building for Carvana,...
Dermapharm Holding SE recently reported its second quarter and six-month 2025 earnings, revealing sales of €275.48 million in Q2 and €580.75 million for the half-year, both slightly lower than the year-ago periods.
While quarterly revenue declined, the company achieved higher net income in the second quarter, highlighting a divergence between sales and profitability.
We'll explore how this improvement in quarterly profit despite softer sales shapes Dermapharm Holding's broader investment...
If you are wondering what to make of the recent headlines about Eli Lilly (LLY), you are not alone. The company just scored an FDA Breakthrough Therapy designation for its lung cancer drug olomorasib in combination with pembrolizumab, signaling strong regulatory momentum in oncology. On top of that, Lilly announced encouraging Phase 3 results for orforglipron, its oral GLP-1 candidate for obesity and type 2 diabetes, a space that continues to capture investor attention. These late-stage...
If you have been keeping an eye on Arcutis Biotherapeutics (ARQT), you probably noticed the buzz following their recent news. The company just announced the submission of a supplemental New Drug Application to the FDA, aiming to expand the use of ZORYVE cream 0.3% for plaque psoriasis in children as young as two years old. If regulators give the green light, ZORYVE would stand alone as the only topical PDE4 inhibitor approved for this young patient group. This move could carve out a larger...
If you have been keeping an eye on State Street (STT), the latest move is definitely one to pay attention to. The company just announced a new partnership with Apex Fintech Solutions, which includes a minority investment and a plan to build a global digital wealth custody platform. This joint venture will combine State Street’s institutional infrastructure with Apex’s API-driven technology. The aim is to modernize wealth services for advisors and self-directed investors on a global...
If you hold Citigroup (NYSE:C) stock or are watching from the sidelines, the bank’s latest move is hard to ignore. Citigroup is making waves by selecting BlackRock to manage about $80 billion of its global wealth client assets. The new portfolio offering, branded as “Citigroup Portfolio Solutions powered by BlackRock,” is set to launch in the fourth quarter, pending customary approvals. This industry-leading partnership is designed to supercharge Citigroup’s wealth management platform,...
If you’re watching Wells Fargo (WFC) right now, you know it is not just another quiet trading session. The company has been busy, announcing and closing several new fixed-income offerings, ranging from senior unsecured notes due in five to twenty years to subordinated notes that come with higher yields. Moves like these typically prompt investors to pause and consider what they might signal about the company’s balance sheet, future funding needs, and strategic direction. Is Wells Fargo...
RingCentral (RNG) just made headlines with its new partnership as the Chicago Cubs’ official cloud-based business communications provider. This deal is not only about deploying technology; it also includes high-visibility branding opportunities, such as rotational messaging on the iconic Wrigley Field Marquee and bullpen signage. For investors, such an alliance with a marquee sports franchise signals a leap in RingCentral’s efforts to break into new verticals, potentially opening doors to...
If you have been watching Zai Lab (NasdaqGM:ZLAB), the latest approval from the Hong Kong Department of Health is likely on your radar. This green light for TIVDAK, a treatment targeting recurrent or metastatic cervical cancer in adults, gives Zai Lab a bigger foothold in the region and spotlights its role as an exclusive license holder in Greater China. Regulatory review is also under way in mainland China, which hints at further market expansion and revenue potential ahead. For investors,...
